EW Stock Analysis: Edwards Lifesciences Corp
Edwards Lifesciences Corporation is a global medical technology firm specializing in sophisticated products and technologies for structural heart conditions, alongside critical care and surgical patient monitoring. With operations spanning the United States, Europe, Japan, and various international territories, the company offers a comprehensive suite of solutions. Their structural heart disease portfolio encompasses transcatheter heart valve replacement systems designed for minimally invasive procedures, as well a
- Latest close
- $86.32
- 20-day change
- -4.87%
- Trend state
- LEAN BULL
- Classification
- Healthcare · Medical - Devices
Market context
Edwards Lifesciences Corp moved -4.87% over the latest 20-session window. BullRecon currently classifies the broader setup as LEAN BULL.
Latest report
The latest cached company filing period (FY2025 · $6.1B revenue · $1.1B net income) is used alongside annual and quarterly history. Values remain tied to their reported period.
Six-dimension read
Health is currently the strongest dimension at 5.8/6, while Value is the lowest at 3.2/6. Scores are comparative research signals, not forecasts.